You wake after another broken night, notice a sudden flush during a meeting, and wonder whether your poor sleep, anxious mood and difficulty concentrating are all connected. You may also be unsure whether you're in perimenopause, whether hormone replacement therapy (HRT) is appropriate, or whether an online pharmacy can prescribe treatment safely.
Menopause treatment symptoms don't follow one universal pattern. The right option depends on the symptom, your stage of menopause, your medical history, whether you have a uterus, and your preferences. This guide explains the main evidence-based treatments available through UK-regulated care. It's educational information, not a personal treatment recommendation.
Table of Contents
- Understanding Menopause and Why Symptoms Vary
- Common Physical and Psychological Symptoms
- Hormone Replacement Therapy and How It Works
- Non-Hormonal Treatments for Specific Symptoms
- Lifestyle, Topical and Mental Health Support
- UK Safety, Eligibility and Regulatory Standards
- When to Seek Help and How to Access Treatment
- Bringing It All Together
Understanding Menopause and Why Symptoms Vary
Menopause is a gradual change, more like a dimmer switch than an on/off light. During perimenopause, ovarian hormone levels fluctuate, periods may become irregular, and symptoms can start before bleeding stops. Menopause is reached after 12 months without a period. Postmenopause refers to the years afterwards, when hormone levels remain lower and symptoms may continue.
Oestrogen and progesterone affect several body systems. Oestrogen helps regulate temperature, supports vaginal and urinary tissues, bones, sleep and brain function. Changes in progesterone may contribute to altered periods and disrupted sleep. Testosterone also declines over time and may influence sexual desire, energy and muscle function, although testosterone treatment needs specialist consideration.
The NHS explains that menopause usually affects women between 45 and 55, but it can occur earlier. Timing and symptoms vary widely. Removal of the ovaries, smoking, body composition, ethnicity, genetics and the timing of hormonal change may all influence how menopause presents.
Why assessment matters
NICE states that 8 out of 10 women experience some menopause symptoms. Symptoms typically last about 4 years after the last period, while about 10% continue for up to 12 years, according to NICE's menopause quality standard briefing. Symptoms may also begin months or years before periods stop.
This overlap can make diagnosis difficult. Palpitations, anxiety, low mood, poor concentration and fatigue may also occur with thyroid disease, depression, anxiety disorders or cardiac problems. A clinician should assess the complete pattern, rather than assuming every new symptom is caused by hormonal change.
Practical rule: treatment should target the symptoms affecting your life, not simply a hormone result or a label.
The treatment options discussed later match particular symptoms with UK-regulated care, including hormonal and non-hormonal approaches. A GP, menopause specialist or regulated prescriber can help assess suitability, risks and alternatives. This information does not replace an examination, diagnosis or individual risk assessment.
Common Physical and Psychological Symptoms
Symptoms often arrive as a connected chain. A night sweat may interrupt sleep, poor sleep can make concentration harder, and ongoing discomfort may affect mood, intimacy and relationships. Treatment therefore works best when it follows the symptom pattern rather than treating every problem as a single condition.
Physical symptoms
Hot flushes and night sweats are vasomotor symptoms. The brain's temperature-control system becomes unusually sensitive to small changes, so the body may respond with sudden heat, sweating and sometimes chills. NICE's resource impact analysis estimated that 2,068,919 women in England experienced vasomotor symptoms in 2022/23, equal to 21.1% of women, and that 699,001 received HRT, representing 53.9% of women with vasomotor symptoms (NICE resource impact summary). HRT is one treatment option, while non-hormonal medicines and practical measures may suit people who cannot or do not wish to use hormones. XO's guide to hot flush management covers practical approaches.
Vaginal dryness, irritation, urinary urgency and recurrent urinary tract infections can reflect reduced oestrogen effects on vaginal and urinary tissues. These symptoms may start during perimenopause and become more noticeable after periods stop. Vaginal oestrogen, moisturisers, lubricants and assessment for infection are considered according to the symptom and medical history.
Sleep disturbance may follow night sweats, hormonal change, anxiety or a separate sleep disorder. Joint stiffness and muscle aches also have several possible causes, so persistent or severe pain needs assessment rather than automatic menopause treatment. Palpitations, skin or hair changes and weight redistribution can occur, but new or marked symptoms require clinical context.
Psychological and cognitive symptoms
Low mood, anxiety, irritability and emotional fluctuations may be linked with hormonal change, prolonged poor sleep or pressures in midlife. Brain fog usually means difficulty concentrating, finding words or remembering tasks. It does not mean a loss of intelligence or ability. Reduced libido may involve hormonal change, vaginal discomfort, fatigue, mood or relationship factors. For further information about anxiety during this stage, see this resource for expat women in Italy.
A parliamentary briefing found that workplace respondents most often described difficulty sleeping, memory or concentration problems, hot flushes and night sweats. These findings underline why care may need to address sleep, cognition, mood and genitourinary symptoms alongside temperature changes.
Seek same-day assessment for post-menopausal bleeding, chest pain or a sudden severe headache. New neurological symptoms, one-sided leg swelling, severe breathlessness or fainting need urgent medical review, not routine menopause treatment.
Hormone Replacement Therapy and How It Works
HRT replaces some of the oestrogen lost during the menopause transition. If you have a uterus, systemic oestrogen must normally be combined with a progestogen, because unopposed oestrogen can stimulate the womb lining. If you've had a total hysterectomy, oestrogen-only HRT may be suitable, although the reason for surgery and your wider history still matter.
NICE recommends offering HRT for vasomotor symptoms. The British Menopause Society describes HRT as the most effective treatment for hot flushes and night sweats, with evidence from placebo-controlled randomised trials supporting its benefit. Systemic oestrogen can also support bone protection while it's being used, but it isn't automatically suitable for everyone.
Transdermal patches and gels deliver oestrogen through the skin and can provide steady absorption. Oral preparations are another option for some patients. The choice depends on symptoms, age, medical history, migraine pattern, clotting risk, preference and practical factors.
Matching the formulation to the symptom
| HRT formulation | Primary symptoms treated |
|---|---|
| Systemic oestrogen | Hot flushes, night sweats, sleep disruption and broader menopausal symptoms |
| Transdermal oestrogen, such as patches or gels | Systemic symptoms where steady absorption is preferred |
| Combined oestrogen and progestogen | Systemic symptoms when the uterus is present, with progestogen for endometrial protection |
| Oestrogen-only HRT | Systemic symptoms for some people without a uterus |
| Vaginal oestrogen | Vaginal dryness, irritation and urinary symptoms |
| Testosterone | Low sexual desire in selected specialist-led cases when other factors have been assessed |
The British Menopause Society identifies micronised progesterone as the first-choice progestogen in relevant guidance, but prescribing remains individual. Vaginal oestrogen acts locally and is considered separately from systemic HRT.
HRT is prescription-only and requires review. NICE recommends a review at 3 months and then annually to assess benefit, tolerability and adverse effects (NICE recommendations for menopause care). Possible risks include venous thromboembolism and breast cancer, with risk depending on the preparation, duration and personal circumstances. Discuss your history with a prescriber before starting or continuing treatment. You can also read XO's guide to HRT in the UK.
Non-Hormonal Treatments for Specific Symptoms
Non-hormonal treatment may be considered when HRT isn't suitable, is declined, or needs to be avoided. The choice depends on the symptom and the person, rather than on a single alternative being right for everyone.
In July 2025, the MHRA approved elinzanetant, marketed as Lynkuet, as the first global regulatory approval for a non-hormonal treatment specifically for moderate to severe menopause-related vasomotor symptoms (MHRA announcement on elinzanetant). It acts on neurokinin pathways involved in temperature regulation. A UK prescriber still needs to assess suitability, interactions, medical history and monitoring requirements.
SSRIs and SNRIs, including venlafaxine, may be considered for hot flushes, especially where anxiety or low mood also needs treatment. They aren't interchangeable with antidepressant treatment for clinical depression, and a prescriber should review current medicines and mental health history.
Gabapentin can be useful in selected cases, particularly where night-time flushes and sleep disruption are prominent. It can cause dizziness or drowsiness, so the prescriber may need to discuss timing, driving and other sedating medicines. Clonidine is another option, generally considered less often because of tolerability and limited usefulness for some patients.
Vaginal oestrogen deserves careful classification. It's a local hormonal treatment for dryness, irritation and urinary symptoms, rather than a non-hormonal medicine, but it may be considered when systemic HRT isn't wanted or required. A clinician should assess unexplained bleeding and relevant cancer history before prescribing.
| Treatment | Primary symptoms targeted | Key prescribing note |
|---|---|---|
| Elinzanetant | Moderate to severe hot flushes and night sweats | MHRA-approved non-hormonal option; suitability requires prescriber assessment |
| SSRI or SNRI | Flushes, anxiety or low mood | Choice depends on mental health needs, interactions and previous treatment |
| Gabapentin | Night-time flushes and sleep disruption | Drowsiness and dizziness need consideration |
| Clonidine | Vasomotor symptoms | Often considered when other choices aren't suitable |
| Vaginal oestrogen | Dryness, irritation and urinary symptoms | Local treatment; unexplained bleeding requires assessment |
Most of these options are prescription-only treatments. Don't import medicines or buy products from an unregulated website because the packaging, ingredients, storage and clinical oversight may not meet UK standards. For a non-prescription approach to vaginal comfort, XO's information on Replens MD vaginal moisturiser explains how moisturisers differ from prescribed local oestrogen.
Lifestyle, Topical and Mental Health Support
Lifestyle measures can reduce triggers and improve general wellbeing, but they shouldn't be presented as a replacement for effective medical treatment when symptoms are severe. A cool bedroom, layered clothing and identifying personal triggers may make flushes easier to manage, while reducing alcohol, caffeine or spicy foods may help some people, though responses vary.
Cognitive behavioural therapy (CBT) has a specific role. NICE recommends considering CBT for vasomotor symptoms, sleep problems and depressive symptoms associated with menopause. CBT can help change the cycle in which a flush causes worry, worry disrupts sleep, and poor sleep intensifies distress. It isn't a claim that symptoms are imaginary. It's a structured way to address thoughts, behaviour, sleep and coping responses.
Practical support for sleep and comfort
Use consistent sleep and wake times, keep the bedroom comfortable and avoid using the bed for prolonged wakefulness. Stimulus control means going to bed when sleepy, leaving the bed if you can't sleep, and returning when drowsy. A GP should assess persistent insomnia, snoring, restless legs or severe daytime sleepiness because menopause may not be the only cause.
Weight-bearing activity supports bone health, while paced aerobic activity can benefit cardiovascular fitness, mood and sleep. Choose an activity that's realistic and safe for your fitness level. Exercise won't correct every symptom, but regular movement can form a useful part of a broader plan.
Vaginal moisturisers are used regularly to improve ongoing dryness and comfort. Lubricants are used around sexual activity to reduce friction. Neither is the same as vaginal oestrogen, and neither treats systemic symptoms such as hot flushes.
Treatment works best as a combination of appropriate medical care, realistic lifestyle changes and support for the symptom causing the greatest disruption.
Counselling, peer support and mental health services can help when anxiety, low mood or relationship difficulties continue. Seek clinical help if mood symptoms are persistent, worsening, or accompanied by thoughts of self-harm.
UK Safety, Eligibility and Regulatory Standards
Most prescription menopause therapies, including HRT, elinzanetant, SSRIs, SNRIs and gabapentin, are prescription-only medicines. A qualified prescriber must assess whether treatment is clinically appropriate. The NHS confirms that most HRT is prescription-only and that testosterone isn't currently licensed to treat menopause symptoms, although a specialist doctor may prescribe it in selected circumstances (NHS information on HRT).
The MHRA's approval process is the relevant regulatory benchmark for licensed medicines. NICE guidance, including NG23, provides the clinical framework for assessment and treatment. The British Menopause Society's consensus guidance adds specialist context on prescribing choices, risks and follow-up.
A prescriber will consider previous breast cancer, unexplained vaginal bleeding, venous thromboembolism, liver disease, migraine, cardiovascular history, medicines and the reason for any previous surgery. A history of breast cancer or blood clots doesn't mean every treatment is impossible, but it does mean that treatment decisions may require specialist input.
Online care can be appropriate for straightforward presentations when a clinician can obtain enough information to prescribe safely. An online pharmacy should be registered with the General Pharmaceutical Council, commonly called the GPhC, and medicines should be supplied through a UK-regulated prescribing and dispensing model.
An in-person assessment is essential when you need an examination, have unexplained bleeding, a concerning breast symptom, suspected clotting or cardiac disease, new neurological symptoms, or a presentation that doesn't fit typical menopause. Workplace adjustments can also matter, and Pauline Vuyelwa Muswere-Enagbonma's menopause policy guide offers useful context for employers and employees.
When to Seek Help and How to Access Treatment
Seek urgent help for post-menopausal bleeding, chest pain, sudden severe headache, one-sided leg swelling or new neurological symptoms. Don't wait for an online consultation if you're acutely unwell or need examination.
For non-urgent symptoms, book a GP appointment and ask whether a menopause-aware clinician is available. Bring a symptom diary covering periods, flushes, sleep, mood, vaginal or urinary symptoms, medicines and the effect on work or daily life. Blood tests aren't routinely needed for every presentation, but they may be considered when someone is under 45 or the symptoms are atypical.
Your options may include an NHS GP, an NHS menopause clinic where available, a private menopause specialist accredited by the British Menopause Society, or a regulated online service. XO Medical is one example of a UK-registered online pharmacy and telehealth service using UK-registered clinicians for assessment. Any service should explain who prescribes, how follow-up works and which pharmacy dispenses the medicine.
A straightforward pathway is:
- Recognise symptoms: note patterns and red flags.
- Document the impact: record sleep, mood, flushes and genitourinary symptoms.
- Choose a clinician: use NHS, private or regulated online care.
- Discuss options: consider HRT, non-hormonal treatment and supportive measures.
- Arrange follow-up: review response, tolerability and treatment changes at around 8 to 12 weeks, or as your clinician advises.
Bringing It All Together
Effective menopause care matches the treatment to the symptom. Vasomotor symptoms may respond best to systemic HRT or an appropriate non-hormonal prescription, while genitourinary symptoms may need vaginal oestrogen or topical comfort measures. Sleep, mood, libido and cognitive symptoms often require a combined approach.
Self-prescribing, importing unregulated products or using an online service without a registered prescriber carries avoidable risk. Use XO's menopause treatment guides as background reading, then discuss your history, medicines and risk factors with a qualified UK clinician.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any treatment.
XO offers clinician-led menopause assessments through a UK-regulated online healthcare service, including discussion of HRT and other appropriate options where clinically suitable. Visit XO to learn how regulated online consultations and follow-up support may fit alongside NHS or private care.
0 comments